Registrars: | Capita Registrars |
CEO: | Nigel Theobald |
Executive Director: | Luke Cairns |
Executive Director: | David Templeton |
Independent Non-Executive Director: | Alastair Smith |
Non-Executive Chairman: | Chris Britten |
Vice Chairman and CEO: | Michael Palfreyman |
Non-Executive Dir: |
Address: | 6th Floor, 60 Gracechurch Street, London, United Kingdom, EC3V 0HR |
Website: | http://www.n4pharma.com/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BYW8QM32 |
Currency | UK Pounds |
Share Price | 0.43p |
Change Today | 0.050p |
% Change | 13.33 % |
52 Week High | 3.07 |
52 Week Low | 0.35 |
Volume | 1,799,756 |
Shares Issued | 832.28m |
Market Cap | £3.54m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:58 | 50,000 @ 0.44p |
15:42 | 374,045 @ 0.44p |
15:05 | 11,000 @ 0.40p |
15:05 | 150,000 @ 0.40p |
11:36 | 500 @ 0.40p |
You are here: research